Screener
Arcutis Biotherapeutics, Inc. ARQT PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Inventory | 38,879 | 22,634 |
| Prepaid expenses and other current assets | 34,770 | 21,079 |
| Total current assets | 467,671 | 411,232 |
| Property, plant, and equipment, net | 872 | 1,043 |
| Intangible assets, net | 13,687 | 14,812 |
| Operating lease right-of-use asset | 4,253 | 4,467 |
| Other assets | 2,054 | 1,419 |
| Total assets | $488,537 | $432,973 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s PP&E (net)?
- Arcutis Biotherapeutics, Inc. (ARQT) reported PP&E (net) of $872K in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s PP&E (net) changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s PP&E (net) decreased by 37.4% year-over-year, from $1.39M to $872K.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s PP&E (net) has grown at a -12.3% compound annual growth rate (CAGR), from $2.02M to $1.04M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Arcutis Biotherapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude